Dishman Carbogen Amcis Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Nikunj Desai, was filed 16 Feb 2023.
Dishman Carbogen Amcis Limited: what insiders have been doing
Every trade that managers of Dishman Carbogen Amcis Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for Dishman Carbogen Amcis Limited. The previous disclosure was published on 16 February 2023.
In the same sector, recent insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. also feature in our signals. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +99.1%Entry ₹102.95 · Close at T+365 ₹204.95
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 554 shares@ ₹99.89898.7% of flowEquity SharesSEBI:9d06949d5aaf8dd68dd9ebacec3630be8850f3ceCanonical exit: 16 May 2023 (T+90)
- 5,729 shares@ ₹99.749991.3% of flowEquity SharesSEBI:08fe3667eabbdc2bf940b2f501184466ce69e853Canonical exit: 14 May 2023 (T+90)
2 of 2 declarations
About Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited is a company focused on the development and manufacturing of pharmaceutical products. It primarily operates in the healthcare and pharmaceutical sector on the XBOM market.
